EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ultra-Processed Foods and Type 2 Diabetes Mellitus: What Is the Evidence So Far?

Natalia G Vallianou iD, Angelos Evangelopoulos iD, Ilektra Tzivaki, Stavroula Daskalopoulou, Andreas Adamou, Georgia Chrysi Michalaki Zafeiri, Irene Karampela iD, Maria Dalamaga iD, Dimitris Kounatidis iD

Biomolecules · 2025

DOI: 10.3390/biom15020307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Natalia G Vallianou und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Food Handling, Fast Foods. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultra-processed foods (UPFs) are foods that have undergone extensive industrial processing with the addition of various substances in order to make them more tasty, eye-catching, and easy to consume. UPFs are usually rich in sugars, salt, and saturated fat, whereas they lack essential nutrients. The aim of this review is to elaborate upon the current evidence associating overconsumption of UPFs with the development of type 2 diabetes mellitus (T2DM). We will discuss data interconnecting UPFs and T2DM risk and will further describe specific ingredients that have been suggested to increase this risk. In addition, we will thoroughly explain how additives, such as emulsifiers or sweeteners, or other compounds formed during manufacturing, such as acrylamide and acrolein, and during packaging, such as bisphenol-A, are proposed to be implicated in the pathogenesis of insulin resistance and T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Food HandlingFast FoodsHumansInsulin ResistanceFood, Processed

Stichwörter der Autor:innen

additivesartificial sweetenersbisphenol-Atype 2 diabetes mellitusultra processed foods

Autor:innen und Institutionen

  • First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece.
  • Roche Diagnostics Hellas S.A., 15125 Athens, Greece.
  • Second Department of Critical Care, Attikon General University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Diabetes Center, First Department of Propaedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Natalia G Vallianou, Angelos Evangelopoulos, Irene Karampela, Maria Dalamaga, Dimitris Kounatidis

Zitieren

APA

Vallianou, N. G., Evangelopoulos, A., Tzivaki, I., Daskalopoulou, S., Adamou, A., Michalaki Zafeiri, G. C., Karampela, I., Dalamaga, M., & Kounatidis, D. (2025). Ultra-Processed Foods and Type 2 Diabetes Mellitus: What Is the Evidence So Far?. Biomolecules. https://doi.org/10.3390/biom15020307

Vancouver

Vallianou NG, Evangelopoulos A, Tzivaki I, Daskalopoulou S, Adamou A, Michalaki Zafeiri GC, et al. Ultra-Processed Foods and Type 2 Diabetes Mellitus: What Is the Evidence So Far?. Biomolecules. 2025. doi:10.3390/biom15020307

BibTeX
@article{Vallianou2025,
  author = {Vallianou, Natalia G and Evangelopoulos, Angelos and Tzivaki, Ilektra and Daskalopoulou, Stavroula and Adamou, Andreas and Michalaki Zafeiri, Georgia Chrysi and Karampela, Irene and Dalamaga, Maria and Kounatidis, Dimitris},
  title = {Ultra-Processed Foods and Type 2 Diabetes Mellitus: What Is the Evidence So Far?},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15020307}
}
Kostenlos starten →